FDA status of every medication we prescribe
Last updated: November 10, 2026
Every medication Pepti prescribes is compounded: made for you by a licensed U.S. compounding pharmacy on a physician's prescription. Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness or quality before they are dispensed. Many of the peptides below have limited research in people. This page says plainly where each one stands. For what compounding means in general, see our compounded medication disclosure.
The HHS interim policy of October 28, 2026
On October 28, 2026, the U.S. Department of Health and Human Services announced an interim policy for six peptides: BPC-157, TB-500, KPV, MOTS-c, Epitalon and Semax. HHS said it does not intend to take enforcement action against state-licensed pharmacies that compound them while the FDA decides, through rulemaking, whether to add them to the list of substances pharmacies may compound. The policy applies only when every one of its conditions is met, including that each product contains a single peptide and is given in a listed form. It does not make any of these peptides FDA-approved.
Single-ingredient medications we prescribe that the policy names: BPC-157, Epithalon, KPV, MOTS-c, TB-500.
Every medication, one by one
| Medication | Status |
|---|---|
| 5-Amino-1MQ | Compounded medication, not FDA-approved. No FDA-approved drug contains it. |
| Adipotide | Compounded medication, not FDA-approved. No FDA-approved drug contains it. |
| AOD-9604 | Compounded medication, not FDA-approved. No FDA-approved drug contains it. |
| ARA-290 | Compounded medication, not FDA-approved. No FDA-approved drug contains it. |
| ASCEND Blend (CJC-1295 / Ipamorelin / Tesamorelin / IGF-1 LR3) | Compounded medication, not FDA-approved. A blend of CJC-1295, Ipamorelin, Tesamorelin, IGF-1 LR3; no FDA-approved drug combines them. |
| BPC-157 | Compounded medication, not FDA-approved. No FDA-approved drug contains it. BPC-157 is one of six peptides named in HHS's October 28, 2026 interim policy on pharmacy compounding. |
| BPC-157 + TB-500 | Compounded medication, not FDA-approved. A blend of BPC-157, TB-500; no FDA-approved drug combines them. |
| CJC-1295 / Ipamorelin | Compounded medication, not FDA-approved. A blend of CJC-1295, Ipamorelin; no FDA-approved drug combines them. |
| Dihexa | Compounded medication, not FDA-approved. No FDA-approved drug contains it. |
| DSIP (Delta Sleep Inducing Peptide) | Compounded medication, not FDA-approved. No FDA-approved drug contains it. |
| ELEVATE Blend (Semax / Selank / BPC-157 / KPV) | Compounded medication, not FDA-approved. A blend of Semax, Selank, BPC-157, KPV; no FDA-approved drug combines them. |
| Epithalon | Compounded medication, not FDA-approved. No FDA-approved drug contains it. Epithalon is one of six peptides named in HHS's October 28, 2026 interim policy on pharmacy compounding. |
| ETERNAL Blend (GHK-Cu / BPC-157 / TB-500 / Epithalon) | Compounded medication, not FDA-approved. A blend of GHK-Cu, BPC-157, TB-500, Epithalon; no FDA-approved drug combines them. |
| EUPHORIA Blend (MOTS-c / BPC-157 / GHK-Cu / Kisspeptin-10) | Compounded medication, not FDA-approved. A blend of MOTS-c, BPC-157, GHK-Cu, Kisspeptin-10; no FDA-approved drug combines them. |
| FORTIFY Blend (Thymosin Alpha-1 / BPC-157 / KPV / LL-37) | Compounded medication, not FDA-approved. A blend of Thymosin Alpha-1, BPC-157, KPV, LL-37; no FDA-approved drug combines them. |
| FOXO4-DRI | Compounded medication, not FDA-approved. No FDA-approved drug contains it. |
| FUSION Blend (BPC-157 / MOTS-c / 5-Amino-1MQ / Tesamorelin) | Compounded medication, not FDA-approved. A blend of BPC-157, MOTS-c, 5-Amino-1MQ, Tesamorelin; no FDA-approved drug combines them. |
| GHK-Cu | Compounded medication, not FDA-approved. No FDA-approved drug contains it. |
| GLOW (BPC-157 / GHK-Cu / TB-500) | Compounded medication, not FDA-approved. A blend of several ingredients; no FDA-approved drug combines them. |
| Glutathione | Compounded medication, not FDA-approved. No FDA-approved drug contains it. |
| Hexarelin | Compounded medication, not FDA-approved. No FDA-approved drug contains it. |
| IGF-1 LR3 | Compounded medication, not FDA-approved. No FDA-approved drug contains it. |
| Ipamorelin | Compounded medication, not FDA-approved. No FDA-approved drug contains it. |
| Ipamorelin + Sermorelin | Compounded medication, not FDA-approved. A blend of Ipamorelin, Sermorelin; no FDA-approved drug combines them. |
| Kisspeptin | Compounded medication, not FDA-approved. No FDA-approved drug contains it. |
| KLOW Blend | Compounded medication, not FDA-approved. A blend of BPC-157, TB-500, GHK-Cu, KPV; no FDA-approved drug combines them. |
| KPV | Compounded medication, not FDA-approved. No FDA-approved drug contains it. KPV is one of six peptides named in HHS's October 28, 2026 interim policy on pharmacy compounding. |
| Melanotan II | Compounded medication, not FDA-approved. No FDA-approved drug contains it. |
| MOTS-c | Compounded medication, not FDA-approved. No FDA-approved drug contains it. MOTS-c is one of six peptides named in HHS's October 28, 2026 interim policy on pharmacy compounding. |
| NAD+ Injection | Compounded medication, not FDA-approved. No FDA-approved drug contains it. |
| NAD+ Injection (500 mg) | Compounded medication, not FDA-approved. No FDA-approved drug contains it. |
| Oxytocin | Compounded medication, not FDA-approved. Its active ingredient is in an FDA-approved brand-name drug; this compounded version is not that drug. |
| PE-22-28 | Compounded medication, not FDA-approved. No FDA-approved drug contains it. |
| PHYSIQ Blend (Tesamorelin / Ipamorelin / AOD-9604 / MOTS-c) | Compounded medication, not FDA-approved. A blend of Tesamorelin, Ipamorelin, AOD-9604, MOTS-c; no FDA-approved drug combines them. |
| PT-141 | Compounded medication, not FDA-approved. Its active ingredient is in an FDA-approved brand-name drug; this compounded version is not that drug. |
| PT-141 + Oxytocin | Compounded medication, not FDA-approved. A blend of PT-141, Oxytocin; no FDA-approved drug combines them. |
| RADIANCE Blend (GHK-Cu / Tesamorelin) | Compounded medication, not FDA-approved. A blend of GHK-Cu, Tesamorelin; no FDA-approved drug combines them. |
| REVIVE Blend (GHK-Cu / CJC-1295 / Ipamorelin / TB-500) | Compounded medication, not FDA-approved. A blend of GHK-Cu, CJC-1295, Ipamorelin, TB-500; no FDA-approved drug combines them. |
| Selank | Compounded medication, not FDA-approved. No FDA-approved drug contains it. |
| Semaglutide | Compounded medication, not FDA-approved. Its active ingredient is in an FDA-approved brand-name drug; this compounded version is not that drug. |
| Semax | Compounded medication, not FDA-approved. No FDA-approved drug contains it. |
| Semax + Selank | Compounded medication, not FDA-approved. A blend of several ingredients; no FDA-approved drug combines them. |
| SERENITY Blend (DSIP / Selank / CJC-1295 / Ipamorelin) | Compounded medication, not FDA-approved. A blend of DSIP, Selank, CJC-1295, Ipamorelin; no FDA-approved drug combines them. |
| Sermorelin | Compounded medication, not FDA-approved. A brand-name version was once FDA-approved and has since been discontinued by its maker. |
| SHRED Blend (AOD-9604 / CJC-1295 / Ipamorelin / MOTS-c) | Compounded medication, not FDA-approved. A blend of AOD-9604, CJC-1295, Ipamorelin, MOTS-c; no FDA-approved drug combines them. |
| SLU-PP-332 | Compounded medication, not FDA-approved. No FDA-approved drug contains it. |
| SS-31 (Elamipretide) | Compounded medication, not FDA-approved. Its active ingredient is in an FDA-approved brand-name drug; this compounded version is not that drug. |
| SYNAPSE Blend (Semax / Selank / MOTS-c / Tesamorelin) | Compounded medication, not FDA-approved. A blend of Semax, Selank, MOTS-c, Tesamorelin; no FDA-approved drug combines them. |
| TB-500 | Compounded medication, not FDA-approved. No FDA-approved drug contains it. TB-500 is one of six peptides named in HHS's October 28, 2026 interim policy on pharmacy compounding. |
| Tesamorelin | Compounded medication, not FDA-approved. Its active ingredient is in an FDA-approved brand-name drug; this compounded version is not that drug. |
| Tesamorelin + Ipamorelin | Compounded medication, not FDA-approved. A blend of several ingredients; no FDA-approved drug combines them. |
| Thymalin | Compounded medication, not FDA-approved. No FDA-approved drug contains it. |
| Thymosin Alpha-1 | Compounded medication, not FDA-approved. No FDA-approved drug contains it. |
| Tirzepatide | Compounded medication, not FDA-approved. Its active ingredient is in an FDA-approved brand-name drug; this compounded version is not that drug. |
| TITAN Blend (Tesamorelin / CJC-1295 / Ipamorelin / BPC-157) | Compounded medication, not FDA-approved. A blend of Tesamorelin, CJC-1295, Ipamorelin, BPC-157; no FDA-approved drug combines them. |
How we prescribe them
A licensed physician reviews your health history before anything is prescribed, and may decline. Your medication is made by a licensed U.S. compounding pharmacy and shipped to you. Questions about a specific medication: email support@hellopepti.com.